Breaking News Instant updates and real-time market news.

TWLO

Twilio

$60.58

-0.11 (-0.18%)

, KGC

Kinross Gold

$3.52

0.02 (0.57%)

08:45
10/10/16
10/10
08:45
10/10/16
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Twilio (TWLO) 91.57% +5.24, Kinross (KGC) 1.65% +1.40, Himax Technologies (HIMX) 12.41% +1.39, Mylan (MYL) 0.64% +0.39, YY (YY) 1.71% +0.33, Under Armour (UA) 2.40% +0.28, Potash (POT) 0.56% +0.27, Restoration Hardware (RH) 5.16% +0.25, P&G (PG) 0.99% +0.21, and Widsomtree Japan (DXJ) 0.71% +0.14.

TWLO

Twilio

$60.58

-0.11 (-0.18%)

KGC

Kinross Gold

$3.52

0.02 (0.57%)

HIMX

Himax

$8.64

0.06 (0.70%)

MYL

Mylan

$35.94

-0.9 (-2.44%)

YY

YY

$53.19

-1.78 (-3.24%)

UA

Under Armour

$37.78

-0.04 (-0.11%)

POT

Potash

$15.98

-0.2 (-1.24%)

RH

Restoration Hardware

$33.67

-0.54 (-1.58%)

PG

Procter & Gamble

$90.00

0.78 (0.87%)

DXJ

WisdomTree Japan Hedged Equity Fund

$43.68

-0.33 (-0.75%)

  • 11

    Oct

  • 25

    Oct

  • 25

    Oct

  • 03

    Nov

  • 03

    Nov

  • 09

    Nov

  • 14

    Nov

  • 16

    Nov

  • 08

    Dec

  • 28

    Mar

TWLO Twilio
$60.58

-0.11 (-0.18%)

08/25/16
ARGS
08/25/16
INITIATION
ARGS
Hold
Twilio initiated with a Hold at Argus
Argus analysts Stephen Biggar and Mike Jaffe say that Twilio's opportunists should increase significantly going forward, but they predict that it will report losses "for several more quarters." The analysts say that the stock appears to be "fully valued" at current levels.
08/25/16
08/25/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cree (CREE) initiated with a Buy at Roth Capital. 2. Reynolds American (RAI) initiated with a Neutral at UBS. 3. Twilio (TWLO) initiated with a Hold at Argus. 4. Phillips 66 Partners (PSXP) initiated with a Neutral at Goldman. 5. WD-40 (WDFC) initiated with a Hold at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/16
JPMS
07/18/16
INITIATION
Target $39
JPMS
Neutral
Twilio initiated with a Neutral at JPMorgan
JPMorgan analyst Mark Murphy started Twilio with a Neutral rating and $39 price target.
07/18/16
07/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Twilio (TWLO) initiated with a Neutral at Goldman, an Outperform at William Blair, a Hold at Canaccord, a Sector Weight at Pacific Crest, a Market Perform at JMP Securities, and with a Neutral at JPMorgan. 2. Selecta Biosciences (SELB) initiated with a Buy at UBS, a Buy at Stifel, a Buy at Canaccord, and a Buy at Needham. 3. China Mobile (CHL) and China Telecom (CHA) assumed with a Buy at Jefferies. 4. NetEase (NTES) initiated with a Buy at Brean Capital. 5. Sysco (SYY) reinstated with a Hold at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
KGC Kinross Gold
$3.52

0.02 (0.57%)

09/07/16
09/07/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Navistar (NAV) initiated with a Hold at Deutsche Bank. 2. Barrick Gold (ABX) initiated with a Sell at Berenberg while the firm initiated Randgold (GOLD), Kinross Gold (KGC), and Goldcorp (GG) with a Hold. 3. 3. After the close on Tuesday, Deutsche Bank analysts Nicole DeBlase, Saree Boroditsky, and Kevin Marek initiated the U.S. Machinery group with a "cautious view." Oshkosh (OSK), Caterpillar (CAT), and Wabtec (WAB) were initiated with Buy ratings at Deutsche Bank, while the firm initiated Cummins (CMI) and CNH Industrial (CNHI) with Sell ratings. The firm also initiated Deere (DE), AGCO (AGCO), Terex (TEX), PACCAR (PCAR), WABCO (WBC), and United Rentals (URI) with Hold ratings. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/16
BREN
09/07/16
INITIATION
Target $4.6
BREN
Hold
Kinross Gold initiated with a Hold at Berenberg
Berenberg analyst Yuriy Vlasov initiated Kinross Gold with a Hold and $4.60 price target.
08/02/16
SBSH
08/02/16
INITIATION
Target $5.5
SBSH
Neutral
Kinross Gold initiated with a Neutral at Citi
Citi analyst Alexander Hacking started Kinross Gold with a Neutral rating and $5.50 price target.
07/14/16
JEFF
07/14/16
UPGRADE
Target $6
JEFF
Hold
Kinross Gold upgraded to Hold from Underperform at Jefferies
Jefferies analyst Christopher LaFemina upgraded Kinross Gold (KGC) to Hold after his firm increased its gold price forecasts to reflect ongoing elevated macro risk. Investment demand should support the gold price to a near-term peak of at least $1,400/oz, LaFemina tells investors in a research note. He raised his price target for Kinross shares to $6 from $4. LaFemina this morning also upgraded Barrick Gold (ABX) and Randgold Resources (GOLD) to Buy.
HIMX Himax
$8.64

0.06 (0.70%)

09/29/16
FBCO
09/29/16
NO CHANGE
FBCO
Outperform
Himax long-term story intact, says Credit Suisse
Credit Suisse analyst Jerry Su lowered Himax's LCOS/WLO shipment assumptions for Q4-1H 2017 on slower new platform adoption following supply chain checks. Su said the 2018 AR device ramp is on track and believes Himax's long-term story on consumer AR glass and 3D sensing for smartphone remains intact, since the capacity ramp up remains on schedule. The analyst said the potential launch of consumer AR glass and 3D sensing for smartphone should boost Himax's earnings in 2018 and reiterates his Outperform rating and $14 price target.
09/28/16
ROTH
09/28/16
INITIATION
Target $10
ROTH
Buy
Himax initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Himax with a Buy and a $10 price target. Desilva believes newer HIMX products can participate in growth of IoT device categories such as augmented reality and virtual reality head-mounted devices.
09/26/16
NOMU
09/26/16
DOWNGRADE
NOMU
Neutral
Himax downgraded to Neutral from Buy at Nomura
09/02/16
NOMU
09/02/16
NO CHANGE
Target $12
NOMU
Buy
Himax price target raised to $12 on better pricing at Nomura
Nomura analyst Donnie Teng noted that Himax has been able to raise its prices for its liquid crystal on silicon, or LCOS, and wafer level optics, or WLO, for a major augmented reality device recently, which he believes could help the company reach the higher end of its Q3 sales guidance. Teng raised his price target on Himax shares to $12 from $9.70, adding that the company plans to try to provide more cost effective LCOS and WLO products for a possible consumer AR device in 2018, which lead to higher demand. Nomura keeps a Buy rating on the stock.
MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.
10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.
YY YY
$53.19

-1.78 (-3.24%)

09/15/16
FBCO
09/15/16
INITIATION
Target $64
FBCO
Outperform
YY initiated with an Outperform at Credit Suisse
Credit Suisse analyst Zoe Zhao initiated YY with an Outperform and a $64 price target. The analyst is positive on YY due to its proven track record and recurring cash flow from PC livestreaming with optionality from mobile product evolution and adequate margin of safety on valuation.
09/14/16
FBCO
09/14/16
INITIATION
Target $64
FBCO
Outperform
YY initiated with an Outperform at Credit Suisse
Target $64.
08/31/16
JPMS
08/31/16
INITIATION
Target $62
JPMS
Overweight
YY initiated with an Overweight at JPMorgan
JPMorgan analyst Alex Yao started YY with an Overweight rating and $62 price target. The company is well positioned to transition from PC broadcasting to mobile, Yao tells investors in a research note.
UA Under Armour
$37.78

-0.04 (-0.11%)

09/30/16
GUGG
09/30/16
INITIATION
Target $50
GUGG
Buy
Under Armour initiated with a Buy at Guggenheim
Guggenheim analyst Robert Drbul initiated Under Armour with a Buy and a $50 price target as he expects growth in the strong activewear/athletic category to continue and believes a premium multiple is warranted.
10/10/16
WELS
10/10/16
UPGRADE
WELS
Outperform
Under Armour upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Tom Nikic upgraded Under Armour to Outperform saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales reacceleration over the next 12-18 months. The analyst believes Under Armour's growth story is intact heading into 2017 and that its inventory levels are improving. Nikic raised his price target range for the shares to $44-$46 from $38-$42.
09/13/16
09/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chevron (CVX) initiated with an Outperform at BMO Capital. 2. AB InBev (BUD) initiated with a Buy at Jefferies. 3. Altria Group (MO) and Reynolds American (RAI) were initiated with a Buy at Citi while the firm initiated Philip Morris (PM) with a Neutral. 4. Under Armour (UA) initiated with a Neutral at Nomura. 5. Xerox (XRX) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
ROTH
10/06/16
NO CHANGE
Target $22.5
ROTH
Buy
Under Armour deal should drive MINDBODY platform exposure, says Roth Capital
Roth Capital analyst Darren Aftahi notes that Under Armour (UA) has announced integration of its popular MyFitnessPal application with MINDBODY's (MB) platform. The partnership will enable users to search, book and pay for fitness classes directly on the app, which the analyst believes should be beneficial to MINDBODY's subscribers and its business in general. While it is unclear whether the deal with Under Armour is exclusive, the analyst believes it could open the door for MINDBODY to strike similar deals with other large fitness apparel companies like Nike (NKE) and its Nike+ mobile application. He reiterates a Buy rating and $22.50 price target on MINDBODY's shares.
POT Potash
$15.98

-0.2 (-1.24%)

09/26/16
SUSQ
09/26/16
UPGRADE
Target $21
SUSQ
Positive
Potash upgraded to Positive at Susquehanna
As previously reported, Susquehanna analyst Don Carson upgraded Potash (POT) to Positive from Neutral, citing expected benefits from the company's proposed merger with Agrium (AGU), which he sees as having relatively low antitrust risk compared to the other mega-mergers being pursued in the Ag space. The firm, which also has a Positive rating for Agrium shares, raised its price target on Potash to $21 from $16 increased its price target on Agrium to $116 from $109.
10/10/16
RBCM
10/10/16
UPGRADE
RBCM
Outperform
Potash upgraded on merger at RBC Capital
As noted on Friday, RBC Capital upgraded Potash (POT) to Outperform from Sector Perform. RBC Capital analyst Andrew Wong says that the estimated synergies of the Agrium (AGU)/Potash merger are "compelling." Wong calls the synergies "ambitious but achievable," and adds that the strategic benefits of the deal are "just as important as synergies." He thinks that the benefits of the deal "outweigh potential risks related to changing potash exposure." Target to $19 from $15.
09/26/16
09/26/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Hold from Reduce at HSBC. 2. Potash (POT) upgraded to Positive from Neutral at Susquehanna with analyst Don Carson citing expected benefits from the company's proposed merger with Agrium (AGU), which he sees as having relatively low antitrust risk compared to the other mega-mergers being pursued in the Ag space. 3. Oshkosh (OSK) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 4. Marriott (MAR) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen citing strong unit growth. 5. NetApp (NTAP) upgraded to Buy from Hold at Cross Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
RBCM
10/07/16
UPGRADE
RBCM
Outperform
Potash upgraded to Outperform from Sector Perform at RBC Capital
RH Restoration Hardware
$33.67

-0.54 (-1.58%)

09/29/16
OPCO
09/29/16
NO CHANGE
OPCO
Restoration Hardware rally a selling opportunity, says Oppenheimer
10/07/16
BUCK
10/07/16
UPGRADE
Target $34
BUCK
Neutral
Restoration Hardware upgraded to Neutral from Underperform at Buckingham
Buckingham upgraded Restoration Hardware to Neutral and raised its price target to $34 from $30. The firm's analyst believes $1.60-$1.80 FY16 earnings are achievable, reducing the risk of further downward earnings revisions.
10/07/16
10/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Gap (GPS) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying the company's near-to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. 2. DuPont Fabros (DFT) upgraded to Buy from Hold at Stifel with analyst Matthew Heinz saying the company's current valuation reflects an expectation for weaker Q3 leasing activity. 3. Ralph Lauren (RL) upgraded to Conviction Buy from Buy at Goldman with analyst Lindsay Drucker Mann saying CEO Stefan Larsson's turnaround is firmly in place. 4. Restoration Hardware (RH) upgraded to Neutral from Underperform at Buckingham with the firm's analyst believing $1.60-$1.80 fiscal 2016 earnings are achievable, reducing the risk of further downward earnings revisions. 5. Vivint Solar (VSLR) upgraded to Neutral from Sell at Goldman with analyst Brian Lee saying the company is "moving on the path toward recovery." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
DBAB
09/09/16
NO CHANGE
Target $40
DBAB
Hold
Restoration Hardware Q2 upside driven by pull forward, says Deutsche Bank
Deutsche Bank analyst Adam Sindler attributes Restoration Hardware's upside in Q2 to pull forward from Q3. The pull forward of sales into Q2 from Q3 is primarily related to outdoor furniture, Sindler tells investors in a research note. He points out the company reiterated its annual guidance despite the upside in Q2. Nonetheless, the analyst believes Restoration's trends are stabilizing and he upped his price target for the shares to $40 from $28. Sindler reiterates a Hold rating on the name. The stock is up 11% to $39.00 in pre-market trading.
PG Procter & Gamble
$90.00

0.78 (0.87%)

07/22/16
STFL
07/22/16
NO CHANGE
STFL
Procter & Gamble price target raised to $92 from $85 at Stifel
Stifel expects Procter & Gamble's stock to be boosted by multiple expansion, driven by improving organic sales in fiscal 2017. The firm says that the company's margins should continue to expand. It believes that the stock's valuation is attractive, and it keeps a Buy rating on the shares.
08/15/16
RILY
08/15/16
UPGRADE
Target $105
RILY
Buy
Procter & Gamble upgraded to Buy from Neutral at B. Riley
B. Riley analyst Linda Bolton Weiser upgraded Procter & Gamble to Buy saying she left a meeting with new CEO David Taylor with greater confidence in the company's improved organic sales growth. The analyst expects Procter & Gamble's multiple to continue expanding and she upped her price target for the shares to $105 from $74.
08/15/16
08/15/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) upgraded to Buy from Neutral at B. Riley with analyst Linda Bolton Weiser saying she left a meeting with new Chief Executive Officer David Taylor with greater confidence in the company's improved organic sales growth. 2. Valeant (VRX) upgraded to Neutral from Underperform at Mizuho. 3. AAC Holdings (AAC) upgraded to Strong Buy from Outperform at Raymond James with analyst John Ransom ting favorable valuation, still high short interest, and good visibility on 2017 EBITDA, which is $8M above Street estimates. 4. American Eagle (AEO) upgraded to Buy from Hold at Deutsche Bank with analyst Tiffany Kanaga saying denim strength should drive upside to estimates in the second quarter while easier compares should keep the momentum going in the second half of 2016. 5. Bright Horizons (BFAM) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Steinerman saying the company is entering a period of above-average margin expansion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/26/16
JEFF
08/26/16
NO CHANGE
Target $75
JEFF
Hold
Jefferies cuts Edgewell Personal Care target citing Harry's rollout at Target
Jefferies analyst Kevin Grundy lowered his price target on Edgewell Personal Care (EPC) to $75 from $77 after Harry's shave club offerings launched nationwide at Target (TGT), saying his store checks revealed strong in-store execution for the roll-out. Grundy thinks soon-to-be acquired Dollar Shave Club will also to push into retail and expects other retailers, perhaps including Walmart (WMT), to follow Target's lead and offer shelf space to the "trendy" shave club brands. While saying this is also a risk to Procter & Gamble (PG), Grundy keeps his Buy rating and $98 price target on P&G shares, saying increased levels of investment in U.S. shaving are already factored in the company's guidance.
DXJ WisdomTree Japan Hedged Equity Fund
$43.68

-0.33 (-0.75%)

TODAY'S FREE FLY STORIES

CLI

Mack-Cali Realty

$29.17

0.64 (2.24%)

06:37
12/09/16
12/09
06:37
12/09/16
06:37
Downgrade
Mack-Cali Realty rating change  »

Mack-Cali Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXP

Boston Properties

$129.50

0.66 (0.51%)

06:36
12/09/16
12/09
06:36
12/09/16
06:36
Downgrade
Boston Properties rating change  »

Boston Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNR

Vanguard Natural

$1.12

0.1083 (10.72%)

06:35
12/09/16
12/09
06:35
12/09/16
06:35
Downgrade
Vanguard Natural rating change  »

Vanguard Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDSN

Hudson Technologies

$7.33

0.01 (0.14%)

06:35
12/09/16
12/09
06:35
12/09/16
06:35
Syndicate
Hudson Technologies 6.429M share Secondary priced at $7.00 »

William Blair and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 09

    Dec

NVCR

Novocure

$8.75

0.4 (4.79%)

06:34
12/09/16
12/09
06:34
12/09/16
06:34
Conference/Events
Novocure to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

LFUS

Littelfuse

$154.58

3.1 (2.05%)

06:33
12/09/16
12/09
06:33
12/09/16
06:33
Earnings
Littelfuse backs Q4 adjusted EPS view $1.45-$1.59, consensus $1.52 »

Backs Q4 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FLR

Fluor

$56.00

1.33 (2.43%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIMO

Gigamon

$47.95

-0.4 (-0.83%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Upgrade
Gigamon rating change  »

Gigamon upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WNC

Wabash

$15.13

0.44 (3.00%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Initiation
Wabash initiated  »

Wabash initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PH

Parker-Hannifin

$141.89

-3.09 (-2.13%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Initiation
Parker-Hannifin initiated  »

Parker-Hannifin initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$72.20

0.19 (0.26%)

, VLKAY

Volkswagen

$28.75

-0.188 (-0.65%)

06:32
12/09/16
12/09
06:32
12/09/16
06:32
Periodicals
Daimler CEO says company will be 2016's biggest luxury carmaker, Reuters says »

Daimler CEO Dieter…

DDAIF

Daimler AG

$72.20

0.19 (0.26%)

VLKAY

Volkswagen

$28.75

-0.188 (-0.65%)

BMWYY

BMW

$31.39

0.205 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

GWR

Genesee & Wyoming

$79.54

1.77 (2.28%)

06:31
12/09/16
12/09
06:31
12/09/16
06:31
Hot Stocks
Genesee & Wyoming reports November traffic up 3.7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

06:30
12/09/16
12/09
06:30
12/09/16
06:30
Downgrade
DAVIDsTEA rating change  »

DAVIDsTEA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCN

Waste Connections

$76.63

0.04 (0.05%)

06:29
12/09/16
12/09
06:29
12/09/16
06:29
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPR

Spirit AeroSystems

$61.26

0.65 (1.07%)

06:28
12/09/16
12/09
06:28
12/09/16
06:28
Downgrade
Spirit AeroSystems rating change  »

Spirit AeroSystems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$81.74

1.4 (1.74%)

06:26
12/09/16
12/09
06:26
12/09/16
06:26
Upgrade
Autodesk rating change  »

Autodesk upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

WEGRY

Weir Group

$11.65

-0.08 (-0.68%)

06:26
12/09/16
12/09
06:26
12/09/16
06:26
Downgrade
Weir Group rating change  »

Weir Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVRR

CVR Refining

$10.40

1.25 (13.66%)

06:25
12/09/16
12/09
06:25
12/09/16
06:25
Upgrade
CVR Refining rating change  »

CVR Refining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$11.99

0.09 (0.76%)

06:25
12/09/16
12/09
06:25
12/09/16
06:25
Downgrade
Barclays rating change  »

Barclays downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

PACCAR

$68.07

0.44 (0.65%)

06:24
12/09/16
12/09
06:24
12/09/16
06:24
Upgrade
PACCAR rating change  »

PACCAR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$71.48

-0.07 (-0.10%)

06:23
12/09/16
12/09
06:23
12/09/16
06:23
Downgrade
Oshkosh rating change  »

Oshkosh downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$6.18

0.07 (1.15%)

06:22
12/09/16
12/09
06:22
12/09/16
06:22
Downgrade
Manitowoc rating change  »

Manitowoc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMT

Kennametal

$34.21

0.16 (0.47%)

06:21
12/09/16
12/09
06:21
12/09/16
06:21
Downgrade
Kennametal rating change  »

Kennametal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$57.29

0.01 (0.02%)

06:20
12/09/16
12/09
06:20
12/09/16
06:20
Periodicals
Wells Fargo names four board members for sales scandal review, Reuters reports »

Wells Fargo named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$2.73

0.07 (2.63%)

06:20
12/09/16
12/09
06:20
12/09/16
06:20
Hot Stocks
UniCredit to sell 32.8% stake in Bank Pekao to PZN, PFR »

UniCredit announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.